Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Many patients notice reduced appetite within the first days of treatment
To date, no clinical trials have studied thymosin alpha-1 therapy in people with PsA or other autoimmune diseases
Greig, he's from NIH or from NIA, I can't remember, right
In July 2023, Roche and AInylam reached an agreement to obtain the cooperative development and commercialization rights of the drug for a total transaction value of up to $2.8 billion
What the premium pays for is the bit the medication cant do on its own: A named, qualified clinician or dietitian who knows your history and isnt a rotating call centre Support building healthy habits to prevent weight regain, not just the prescription Support managing side effects so you dont end up reducing your dose unnecessarily A tapering protocol for when you eventually come off the medication, or maintain at a lower dose, designed to protect against regain Whether thats worth 50-150 a month depends on whether youd build those habits and stick to the plan without support
This sequential approach serves two purposes: first, to eliminate immortal time bias by properly aligning treatment initiation with follow-up start (T0) and, second, to maximize statistical power by allowing individuals to contribute data across multiple trials
US$ 26.69
US$ 21.27
US$ 26.62
US$ 28.80
US$ 28.56
US$ 21.21
US$ 27.34
